[48F1-48F1];[49A1-49A1];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
48F1;49A1
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
The presence of P+PBac{XP5.WH5}BSC425 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of the progenitor P{XP}d01323 insertion to be Release 3 genomic coordinate 7323750 on chromosome arm 2R. The Gene Disruption project determined the insertion site of the progenitor P{XP}d01323 insertion to be Release 3 genomic coordinate 7323998 on arm 2R. This corresponds to 48F1 on the Release 3 and Release 5 genome maps. The predicted position of PBac{WH}CG13155f03327 on the Release 5 map is 49A1. Consequently, the cytological breakpoints of Df(2R)BSC425 are predicted to be 48F1;49A1.